To require the National Institutes of Health to conduct and support research using human embryonic stem cells, and for other purposes.
The bill’s titles are written by its sponsor.
Sponsor and status
Sponsor. Representative for Florida's 20th congressional district. Democrat.
Last Updated: Jul 12, 2004
Length: 4 pages
108th Congress, 2003–2004
This bill was introduced on July 12, 2004, in a previous session of Congress, but was not enacted.
Jul 12, 2004
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.
H.R. 4812 (108th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
This bill was introduced in the 108th Congress, which met from Jan 7, 2003 to Dec 9, 2004. Legislation not enacted by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
GovTrack.us. (2019). H.R. 4812 — 108th Congress: Stem Cell Discovery Through Diversity Act. Retrieved from https://www.govtrack.us/congress/bills/108/hr4812
“H.R. 4812 — 108th Congress: Stem Cell Discovery Through Diversity Act.” www.GovTrack.us. 2004. July 22, 2019 <https://www.govtrack.us/congress/bills/108/hr4812>
Stem Cell Discovery Through Diversity Act, H.R. 4812, 108th Cong. (2004).
|title=H.R. 4812 (108th)
|accessdate=July 22, 2019
|author=108th Congress (2004)
|date=July 12, 2004
|quote=Stem Cell Discovery Through Diversity Act
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.